Significant Inhibition of UDP-Glucuronosyltransferase (UGT) 1A1 by Plant Flavonoid Alpinetin

被引:0
|
作者
Gao, Chengcheng [1 ]
Cao, Yue [2 ]
Gao, Xingchun [2 ]
Qu, Yan-Qing [3 ]
Liu, Hui [2 ]
Liu, Huiling [2 ]
Wu, Shangnong [1 ]
Tu, Yanyang [2 ]
Xie, Rui [1 ]
机构
[1] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Gastroenterol, Huaian 223300, Jiangsu, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Expt Surg, Xian 710038, Peoples R China
[3] Yantai Mt Hosp, Yantai, Shandong, Peoples R China
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2012年 / 31卷 / 09期
关键词
Alpinetin; Inhibition; UDP-glucuronosyltransferase (UGT) 1A1;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction between flavonoids and UDP-glucuronosyltransferase (UGT) has been always speculated. The aim of the present study is to investigate the inhibition of many important UGT isoforms by alpinetin which is a bioactive component isolated from Alpinia katsumadai Hayata. Among tested UGT isoforms, alpinetin strongly inhibited the activity of UGT1A1 but showed negligible influence towards other UGT isoforms. Furthermore, the inhibition kinetic type and parameters were determined for the inhibition of alpinetin towards UGT1A1-catalyzed glucuronidation reaction. The intersection in the vertical axis for Lineweaver-Burk plot and in the second quadrant for Dixon plot indicated the competitive inhibition of alpinetin toward UGT1A1. The second plot using the slopes from the Lineweaver-Burk plot towards the concentrations of alpinetin was used to calculate the inhibition parameter (Ki) to be 3.0 mu M. All these results indicated the potential adverse effects induced by the inhibition of UGT1A1 by alpinetin.
引用
收藏
页码:1360 / 1362
页数:3
相关论文
共 50 条
  • [1] Evaluation of Inhibition of UDP-Glucuronosyltransferase (UGT) 1A1 by Demethylzeylasteral
    Yu, Ming-Lian
    Lin, Jia-Ji
    Yang, Yue
    Zhang, Wen-Jing
    Bai, Miao-Chun
    Wang, Cong-Min
    Guo, Yue-Ling
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (07): : 1067 - 1070
  • [2] UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin
    Fujiwara, Ryoichi
    Sumida, Kyohei
    Kutsuno, Yuki
    Sakamoto, Masaya
    Itoh, Tomoo
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (01) : 82 - 88
  • [3] INHIBITION OF ERLOTINIB AGAINST UDP-GLUCURONOSYLTRANSFERASE 1A1
    Liu, Y.
    Ramirez, J.
    House, L. K.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S38 - S38
  • [4] Strong Inhibition Capability of Wogonin towards UDP-Glucuronosyltransferase (UGT) 1A1 and 1A3
    Shan, Li-Na
    Shi, Xian-Bao
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (05): : 741 - 744
  • [5] Strong Inhibition of UDP-Glucuronosyltransferase (UGT) 1A1 by Levothyroxine Indicates the Potential UGT-Inhibition Based Adverse Effect of Levothyroxine
    Zhao, Hua-Dong
    Bao, Guo-Qiang
    He, Xian-Li
    Wu, Tao
    Wang, Cheng-Guo
    Wang, Sheng-Zhi
    Zang, Li
    Lu, Jian-Guo
    Du, Xi-Lin
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (05): : 761 - 763
  • [6] Function, Genetic Polymorphism, and Transcriptional Regulation of Human UDP-glucuronosyltransferase (UGT) 1A1
    Sugatani, Junko
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (02) : 83 - 92
  • [7] Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination
    Jeong, H.
    Choi, S.
    Song, J. W.
    Chen, H.
    Fischer, J. H.
    XENOBIOTICA, 2008, 38 (01) : 62 - 75
  • [8] TokyoGreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1
    Terai, Takuya
    Tomiyasu, Rie
    Ota, Tomoe
    Ueno, Tasuku
    Komatsu, Toru
    Hanaoka, Kenjiro
    Urano, Yasuteru
    Nagano, Tetsuo
    CHEMICAL COMMUNICATIONS, 2013, 49 (30) : 3101 - 3103
  • [9] Accelerated degradation of abnormal UDP-glucuronosyltransferase form 1A1 (UGT1A1) by proteasome
    Emi, Y
    Ohnishi, A
    Ikushiro, S
    Iyanagi, T
    DRUG METABOLISM REVIEWS, 2003, 35 : 58 - 58
  • [10] Glucose induces intestinal human UDP-glucuronosyltransferase (UGT) 1A1 to prevent neonatal hyperbilirubinemia
    Aoshima, Naoya
    Fujie, Yoshiko
    Itoh, Tomoo
    Tukey, Robert H.
    Fujiwara, Ryoichi
    SCIENTIFIC REPORTS, 2014, 4